efspi statistical leaders meeting 8 th june 2011 1
TRANSCRIPT
EFSPI Statistical Leaders Meeting
8th June 2011
1
Welcome
• 2nd European Statistical Leaders Meeting
• Thank you to organising team– Chrissie– Stephen– Maylis– Lesley– Ian
• Thank you Amgen– for Hosting the Meeting
• Introductions2
AgendaTime Topic Presenter/Facilitator 9:00- 9:15 EFPSI President Welcome Address
Organisers welcomeFrancois AubinLesley France
9:15-10:45 Model Based Drug Development Stephen Pyke / Ian Hirsch
10:45-11:00 Break
11:10-12:30 Comparative Drug Effects – Network Meta-analyses Maylis Coste / Chrissie Fletcher
12:30-13:30 Lunch break
13:30-13:45 Update from last Meeting• HTA Update• Risk Benefit
Chrissie Fletcher / Lesley France
13:45 – 14:15 Accreditation of Pharmaceutical Statisticians Egbert Biesheuvel
14:15 – 14:30 Update from last Meeting Professional Development for Statisticians
Hans Uli Burger
14:30 – 14:45 Break14:45 – 16:15 Totality of Evidence – Can we make better use of
ResourcesIan Hirsch / Lesley France
16:15 Meeting summary and Actions
16:30 Meeting Close3
What is EFSPI?
• EFSPI = European Federation of Statisticians in the Pharmaceutical Industry
• Founded in 1992 • EFSPI is an “umbrella”, non-profit making
organisation• A federation of National European Groups• Now have 10 national groups• No individual members• Our national organisations collectively represent
2800 members
4
EFSPI - Our members
SFdS SSL APF DSBS PSDM
BIAS PSI SBS/BVS BBS FMS
5
EFSPI Objectives
• To promote professional standards of statistics and the standing of the statistical profession in the pharmaceutical industry
• To offer a collective expert input on statistical matters to national and international authorities and organisations
• To exchange information on and harmonise attitudes to the practise of statistics in the European Pharma Industry and within member groups
6
EFSPI websitewww.efspi.org
Statistical Leaders Meeting
• Develop a forum for Statistical Leaders to– Network and share ideas – Shape and influence our environment
• Education & Continuing Professional Development• Methodology Development & Identification of Best
Practice• Regulatory and Industry policies• Effective working with differing resourcing models
– Help to shape the strategy for EFSPI
8
Objectives of this meeting
• To identify up to 3 priority actions for the strategic direction of EFSPI in– Professional Development for Statisticians– Model Based Drug Development
– Comparative Drug Effects – Network Meta-analyses.– Utilising the Totality of Evidence
• Provide feedback from our last meeting• Identify experts who would like to be engaged in
European initiatives
9
Format of the meeting
• Each topic will be introduced by a presenter• Facilitated discussion to identify 3 priority
actions• Facilitators will summarise key actions at the
end of each discussion
10
End of meeting
11
Summary and Close
• Review priorities from each session• Identify experts• Take the recommendations to the next council
meeting• Feedback to participants of this meeting in
Autumn
12